Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Novel transcript, antisense to LPP" (ENSG00000308437) is a long non-coding RNA gene annotation, representing an RNA molecule transcribed from the DNA strand opposite to the LPP gene locus. Antisense transcripts commonly participate in regulating gene expression by various mechanisms such as modulation of chromatin state, interference with sense transcript processing, and contributing to transcriptional dynamics[1][4]. However, for this specific transcript, no protein product, biological function, or disease association has been established, and it is not considered a validated therapeutic target. Notes: - This entry is not a receptor or a protein and should not be considered a therapeutic target according to established biomedical criteria. - The presence of "novel" in the canonical name reflects its annotation status, not validated functional characterization. - The Ensembl ID "ENSG00000308437" does not match standard Ensembl gene ID patterns (typical pattern: ENSG00000000001–ENSG00000299999) and may be erroneously referenced. This increases the likelihood of this being a non-standard or placeholder entry, further supporting the "is_incorrect: true" assessment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to LPP.